Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma.
Kai LeiRuihao LiangBinghua TanLin LiYingcheng LyuKexi WangWenjian WangKefeng WangXueting HuDuoguang WuHuayue LinMinghui WangPublished in: Oxidative medicine and cellular longevity (2023)
PTGIS and HRASLS can be used as new therapeutic targets for LUSC as well as biomarkers for prognosis and tumor immunity, which has positive significance for guiding the immunotherapy of LUSC.